Tela Bio Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.9% | -2.3% | -3.1% | +17.8% | -6.9% | +4.9% | +9.1% | +2.4% | +0.9% | -8.7% | +1.2% | – | |
| – | +15.2% | -2.0% | -4.7% | +21.5% | +5.4% | -6.5% | +1.4% | +10.3% | +5.9% | -8.1% | -18.2% | – | |
| – | +11.9% | -2.5% | -2.3% | +16.1% | -12.7% | +11.5% | +12.7% | -1.0% | -1.5% | -9.0% | +11.4% | – | |
| – | +13.4% | -10.9% | -2.9% | -11.0% | -1.9% | +25.2% | -13.3% | +6.6% | -9.3% | +10.1% | +16.2% | – | |
| – | +8.7% | -5.5% | -5.4% | +1.7% | -2.6% | +6.9% | +7.6% | -4.3% | -4.2% | +10.1% | -2.5% | – | |
| – | +16.2% | -32.4% | +40.1% | -1.9% | -11.9% | +17.4% | +0.9% | -7.2% | -5.2% | +13.0% | +0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | -1.0% | -0.1% | +1.0% | -4.5% | -5.0% | -2.5% | +1.1% | +36.3% | +25.4% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -448.7% | – | – | – | – | – | -36.5% | – | – | -58.6% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.